Advancing patient care

Marketed Products

We currently market three FDA-approved products for various neurological conditions.

Product
Gralise® (gabapentin tablets)
Once-daily
Visit the product website for Important Safety Information and download the full Prescribing Information (PDF).
Cambia® (diclofenac potassium)
for Oral solution
Visit the product website for Important Safety Information, including Boxed Warning, and download the full Prescribing Information (PDF).
Zipsor® (diclofenac potassium)
Liquid filled capsules
Visit the product website for Important Safety Information, including Boxed Warning, and download the full Prescribing Information (PDF).

Assertio Therapeutic’s authorized distributers can be found here.